PRINCETON, N.J., Jan. 7, 2011 /PRNewswire/ -- EDDA Technology, a leading provider of advanced computer assisted radiology and surgery solutions, announces today the successful commercial installation of its IQQA®-Liver Enterprise product at Mayo Clinic, Scottsdale, AZ.
As one of the top performing living donor liver transplantation programs in the US, Mayo Clinic will use EDDA Technology's IQQA®-Liver Enterprise in conjunction with its existing technologies by a multidisciplinary team of surgeons and radiologists.
With an innovative toolset for real-time interactive assessment and volumetric quantification of liver, liver lobes, vessels, and other intra-hepatic anatomies, IQQA®-Liver helps physicians enhance efficiency and precision in pre-operative treatment planning and post-surgical follow-up assessment. EDDA's proprietary technology has been used to evaluate more than 1,000 clinical cases at liver surgery/transplantation centers worldwide since the first commercial installation in 2009. IQQA®-Liver has clearance by the FDA and China SFDA, and carries the CE mark.
"To understand each individual's liver anatomy in a quantitative way is essential to ensure the most suitable surgical approach," said David Mulligan, M.D., Chair of Division of Transplant Surgery at Mayo Clinic in Arizona. "EDDA's IQQA®-Liver provides us a comprehensive, quantitative, real-time tool for better treatment planning with confidence. The ability to make accurate calculations and change potential surgical approaches within minutes allows safe planning at optimal patient convenience."
"The successful installation of IQQA®-Liver Enterprise at Mayo Clinic indicates that the value of our technology is once again recognized in assisting physicians to fully utilize the benefits of quantitative imaging modalities," said Dr. Jian-Zhong Qian, President and CEO of EDDA Technology. "EDDA is fully committed to providing total solutions